Hege Kristen
Insider CIK 1299171 · MRSN Director · ADAP Director · RCUS Director · GRPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 734 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 146 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 380 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 138 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,088 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,200 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 257 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,460 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 142 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 400 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 416 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,002 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 101 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 368 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 450 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 578 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 61,500 | — | $0 | 61,500 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 660,000 | — | $0 | 660,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 81,906 | — | $0 | 81,906 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 6,447 | — | $0 | 6,447 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-10-02 | 2023-10-04 | 9,523 | — | $0 | 9,523 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2023-07-19 | 2023-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-07-03 | 2023-07-06 | 3,654 | — | $0 | 3,654 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 18,355 | — | $0 | 18,355 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-12 | 14,467 | — | $0 | 14,467 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-04-03 | 2023-04-05 | 3,451 | — | $0 | 3,451 | SEC↗ |
| GRPH Graphite Bio, Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 10,416 | — | $0 | 10,416 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 25,050 | — | $0 | 25,050 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,547 | — | $0 | 2,547 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-29 | 9,200 | — | $0 | 9,200 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 11,264 | — | $0 | 11,264 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2018-10-19 | 2018-10-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-09-20 | 2018-09-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-01-02 | 2018-01-04 | 3,560 | — | $0 | 3,560 | SEC↗ |